HEADER TRANSFERASE 27-JUN-17 5XVG TITLE CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INHIBITOR CZH226 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PAK4 KINASE DOMAIN (UNP RESIDUES 300-591); COMPND 5 SYNONYM: P21-ACTIVATED KINASE 4,PAK-4; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAK4, KIAA1142; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSUMOH10 KEYWDS ATP BINDING POCKET, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.ZHAO,H.LI REVDAT 2 22-NOV-23 5XVG 1 REMARK REVDAT 1 07-FEB-18 5XVG 0 JRNL AUTH C.HAO,F.ZHAO,H.SONG,J.GUO,X.LI,X.JIANG,R.HUAN,S.SONG, JRNL AUTH 2 Q.ZHANG,R.WANG,K.WANG,Y.PANG,T.LIU,T.LU,W.HUANG,J.WANG, JRNL AUTH 3 B.LIN,Z.HE,H.LI,F.LI,D.ZHAO,M.CHENG JRNL TITL STRUCTURE-BASED DESIGN OF JRNL TITL 2 6-CHLORO-4-AMINOQUINAZOLINE-2-CARBOXAMIDE DERIVATIVES AS JRNL TITL 3 POTENT AND SELECTIVE P21-ACTIVATED KINASE 4 (PAK4) JRNL TITL 4 INHIBITORS. JRNL REF J. MED. CHEM. V. 61 265 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29190083 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01342 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2689 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 16494 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.210 REMARK 3 FREE R VALUE TEST SET COUNT : 859 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.4386 - 3.8146 1.00 2754 144 0.1781 0.2168 REMARK 3 2 3.8146 - 3.0281 1.00 2617 149 0.1807 0.2404 REMARK 3 3 3.0281 - 2.6454 1.00 2595 145 0.1828 0.2525 REMARK 3 4 2.6454 - 2.4036 1.00 2589 131 0.1765 0.2458 REMARK 3 5 2.4036 - 2.2313 1.00 2564 140 0.1832 0.2259 REMARK 3 6 2.2313 - 2.0998 0.99 2516 150 0.2075 0.2745 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.930 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2420 REMARK 3 ANGLE : 0.875 3268 REMARK 3 CHIRALITY : 0.052 365 REMARK 3 PLANARITY : 0.005 417 REMARK 3 DIHEDRAL : 16.957 1472 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5XVG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1300004245. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.2818 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16543 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.10800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.72400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2J0I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.5M MAGNESIUM REMARK 280 FORMATE DIHYDRATE, VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.08450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.63950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.45700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.63950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.08450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.45700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 773 O HOH A 792 2.17 REMARK 500 OG1 THR A 590 O1 EDO A 608 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 440 43.24 -145.29 REMARK 500 ASP A 458 60.23 65.18 REMARK 500 ASN A 537 39.13 -88.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8FX A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 606 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 607 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 608 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 609 DBREF 5XVG A 300 591 UNP O96013 PAK4_HUMAN 300 591 SEQADV 5XVG SER A 299 UNP O96013 EXPRESSION TAG SEQRES 1 A 293 SER SER HIS GLU GLN PHE ARG ALA ALA LEU GLN LEU VAL SEQRES 2 A 293 VAL ASP PRO GLY ASP PRO ARG SER TYR LEU ASP ASN PHE SEQRES 3 A 293 ILE LYS ILE GLY GLU GLY SER THR GLY ILE VAL CYS ILE SEQRES 4 A 293 ALA THR VAL ARG SER SER GLY LYS LEU VAL ALA VAL LYS SEQRES 5 A 293 LYS MET ASP LEU ARG LYS GLN GLN ARG ARG GLU LEU LEU SEQRES 6 A 293 PHE ASN GLU VAL VAL ILE MET ARG ASP TYR GLN HIS GLU SEQRES 7 A 293 ASN VAL VAL GLU MET TYR ASN SER TYR LEU VAL GLY ASP SEQRES 8 A 293 GLU LEU TRP VAL VAL MET GLU PHE LEU GLU GLY GLY ALA SEQRES 9 A 293 LEU THR ASP ILE VAL THR HIS THR ARG MET ASN GLU GLU SEQRES 10 A 293 GLN ILE ALA ALA VAL CYS LEU ALA VAL LEU GLN ALA LEU SEQRES 11 A 293 SER VAL LEU HIS ALA GLN GLY VAL ILE HIS ARG ASP ILE SEQRES 12 A 293 LYS SER ASP SER ILE LEU LEU THR HIS ASP GLY ARG VAL SEQRES 13 A 293 LYS LEU SER ASP PHE GLY PHE CYS ALA GLN VAL SER LYS SEQRES 14 A 293 GLU VAL PRO ARG ARG LYS SEP LEU VAL GLY THR PRO TYR SEQRES 15 A 293 TRP MET ALA PRO GLU LEU ILE SER ARG LEU PRO TYR GLY SEQRES 16 A 293 PRO GLU VAL ASP ILE TRP SER LEU GLY ILE MET VAL ILE SEQRES 17 A 293 GLU MET VAL ASP GLY GLU PRO PRO TYR PHE ASN GLU PRO SEQRES 18 A 293 PRO LEU LYS ALA MET LYS MET ILE ARG ASP ASN LEU PRO SEQRES 19 A 293 PRO ARG LEU LYS ASN LEU HIS LYS VAL SER PRO SER LEU SEQRES 20 A 293 LYS GLY PHE LEU ASP ARG LEU LEU VAL ARG ASP PRO ALA SEQRES 21 A 293 GLN ARG ALA THR ALA ALA GLU LEU LEU LYS HIS PRO PHE SEQRES 22 A 293 LEU ALA LYS ALA GLY PRO PRO ALA SER ILE VAL PRO LEU SEQRES 23 A 293 MET ARG GLN ASN ARG THR ARG MODRES 5XVG SEP A 474 SER MODIFIED RESIDUE HET SEP A 474 10 HET 8FX A 601 29 HET EOH A 602 3 HET EOH A 603 3 HET EOH A 604 3 HET EOH A 605 3 HET EOH A 606 3 HET EDO A 607 4 HET EDO A 608 4 HET EDO A 609 4 HETNAM SEP PHOSPHOSERINE HETNAM 8FX [6-CHLORANYL-4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL) HETNAM 2 8FX AMINO]QUINAZOLIN-2-YL]-[(3R)-3-METHYLPIPERAZIN-1- HETNAM 3 8FX YL]METHANONE HETNAM EOH ETHANOL HETNAM EDO 1,2-ETHANEDIOL HETSYN SEP PHOSPHONOSERINE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 8FX C20 H22 CL N7 O FORMUL 3 EOH 5(C2 H6 O) FORMUL 8 EDO 3(C2 H6 O2) FORMUL 11 HOH *97(H2 O) HELIX 1 AA1 SER A 299 VAL A 312 1 14 HELIX 2 AA2 ASP A 316 SER A 319 5 4 HELIX 3 AA3 ARG A 355 GLN A 357 5 3 HELIX 4 AA4 ARG A 360 MET A 370 1 11 HELIX 5 AA5 LEU A 403 THR A 410 1 8 HELIX 6 AA6 ASN A 413 GLN A 434 1 22 HELIX 7 AA7 LYS A 442 ASP A 444 5 3 HELIX 8 AA8 THR A 478 MET A 482 5 5 HELIX 9 AA9 ALA A 483 SER A 488 1 6 HELIX 10 AB1 PRO A 494 GLY A 511 1 18 HELIX 11 AB2 PRO A 519 ASN A 530 1 12 HELIX 12 AB3 ASN A 537 VAL A 541 5 5 HELIX 13 AB4 SER A 542 LEU A 553 1 12 HELIX 14 AB5 THR A 562 LEU A 567 1 6 HELIX 15 AB6 LYS A 568 ALA A 575 5 8 HELIX 16 AB7 PRO A 577 VAL A 582 1 6 HELIX 17 AB8 PRO A 583 ARG A 586 5 4 SHEET 1 AA1 5 LEU A 321 GLU A 329 0 SHEET 2 AA1 5 ILE A 334 VAL A 340 -1 O THR A 339 N ASP A 322 SHEET 3 AA1 5 LEU A 346 ASP A 353 -1 O VAL A 349 N CYS A 336 SHEET 4 AA1 5 GLU A 390 MET A 395 -1 O MET A 395 N ALA A 348 SHEET 5 AA1 5 MET A 381 VAL A 387 -1 N VAL A 387 O GLU A 390 SHEET 1 AA2 3 GLY A 401 ALA A 402 0 SHEET 2 AA2 3 ILE A 446 LEU A 448 -1 O LEU A 448 N GLY A 401 SHEET 3 AA2 3 VAL A 454 LEU A 456 -1 O LYS A 455 N LEU A 447 SHEET 1 AA3 2 VAL A 436 ILE A 437 0 SHEET 2 AA3 2 ALA A 463 GLN A 464 -1 O ALA A 463 N ILE A 437 LINK C LYS A 473 N SEP A 474 1555 1555 1.32 LINK C SEP A 474 N LEU A 475 1555 1555 1.32 SITE 1 AC1 16 LEU A 310 ILE A 327 GLY A 328 VAL A 335 SITE 2 AC1 16 ALA A 348 LYS A 350 MET A 395 GLU A 396 SITE 3 AC1 16 PHE A 397 LEU A 398 GLU A 399 GLY A 401 SITE 4 AC1 16 ASP A 444 LEU A 447 SER A 457 ASP A 458 SITE 1 AC2 5 ASN A 323 LEU A 362 ASN A 365 GLN A 464 SITE 2 AC2 5 ARG A 472 SITE 1 AC3 5 ARG A 551 ALA A 558 GLN A 559 ARG A 560 SITE 2 AC3 5 GLU A 565 SITE 1 AC4 4 ASN A 323 ALA A 338 THR A 339 PHE A 364 SITE 1 AC5 4 SER A 331 LYS A 356 GLN A 357 GLN A 358 SITE 1 AC6 6 SER A 331 THR A 332 LYS A 350 ASP A 458 SITE 2 AC6 6 PHE A 459 GLY A 460 SITE 1 AC7 5 GLN A 416 ASN A 517 GLU A 518 PRO A 583 SITE 2 AC7 5 HOH A 703 SITE 1 AC8 4 PRO A 520 PRO A 543 ARG A 589 THR A 590 SITE 1 AC9 6 GLU A 366 VAL A 379 MET A 381 MET A 395 SITE 2 AC9 6 ASP A 458 PHE A 459 CRYST1 42.169 64.914 99.279 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023714 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015405 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010073 0.00000